AngioDynamics Beats Estimates With $80.92 Million Q1 Revenue

AngioDynamics posted stronger-than-expected fiscal first-quarter revenue and adjusted earnings while maintaining its fiscal 2026 outlook, extending the medical-device company’s latest operating performance.

Revenue reached $80.92 million, an increase of 6.9% from the same period a year earlier. The result exceeded estimates by $420,000.

Non-GAAP earnings per share came to negative 4 cents, beating estimates by 7 cents. Non-GAAP figures exclude certain expenses to provide a view of underlying operations.

Med Device net sales rose 1.4% to $41 million from $40.4 million in the prior-year period.

AngioDynamics reaffirmed its outlook for fiscal 2026.